1. Biochemistry and Chemical Biology
  2. Structural Biology and Molecular Biophysics
Download icon

A bacteriophage endolysin that eliminates intracellular streptococci

  1. Yang Shen
  2. Marilia Barros
  3. Tarek Vennemann
  4. D Travis Gallagher
  5. Yizhou Yin
  6. Sara B Linden
  7. Ryan D Heselpoth
  8. Dennis J Spencer
  9. David M Donovan
  10. John Moult
  11. Vincent A Fischetti
  12. Frank Heinrich
  13. Mathias Lösche
  14. Daniel C Nelson  Is a corresponding author
  1. University of Maryland, College Park, United States
  2. Carnegie Mellon University, United States
  3. The Rockefeller University, United States
  4. United States Department of Agriculture, United States
Research Article
  • Cited 44
  • Views 3,712
  • Annotations
Cite this article as: eLife 2016;5:e13152 doi: 10.7554/eLife.13152

Abstract

PlyC, a bacteriophage-encoded endolysin, lyses Streptococcus pyogenes (Spy) on contact. Here, we demonstrate that PlyC is a potent agent for controlling intracellular Spy that often underlies refractory infections. We show that the PlyC holoenzyme, mediated by its PlyCB subunit, crosses epithelial cell membranes and clears intracellular Spy in a dose-dependent manner. Quantitative studies using model membranes establish that PlyCB interacts strongly with phosphatidylserine (PS) whereas its interaction with other lipids is weak, suggesting specificity for PS as its cellular receptor. Neutron reflection further substantiates that PlyC penetrates bilayers above a PS threshold concentration. Crystallography and docking studies identify key residues that mediate PlyCB-PS interactions, which are validated by site-directed mutagenesis. This is the first report that a native endolysin can translocate epithelial membranes, thus substantiating the potential of PlyC as an antimicrobial for Spy in the extra- and intracellular milieu and as a scaffold for engineering other functionalities.

Article and author information

Author details

  1. Yang Shen

    Institute for Bioscience and Biotechnology Research, University of Maryland, College Park, Rockville, United States
    Competing interests
    No competing interests declared.
  2. Marilia Barros

    Department of Physics, Carnegie Mellon University, Pittsburgh, United States
    Competing interests
    No competing interests declared.
  3. Tarek Vennemann

    Department of Physics, Carnegie Mellon University, Pittsburgh, United States
    Competing interests
    No competing interests declared.
  4. D Travis Gallagher

    Institute for Bioscience and Biotechnology Research, University of Maryland, College Park, Rockville, United States
    Competing interests
    No competing interests declared.
  5. Yizhou Yin

    Institute for Bioscience and Biotechnology Research, University of Maryland, College Park, Rockville, United States
    Competing interests
    No competing interests declared.
  6. Sara B Linden

    Institute for Bioscience and Biotechnology Research, University of Maryland, College Park, Rockville, United States
    Competing interests
    No competing interests declared.
  7. Ryan D Heselpoth

    Institute for Bioscience and Biotechnology Research, University of Maryland, College Park, Rockville, United States
    Competing interests
    No competing interests declared.
  8. Dennis J Spencer

    Laboratory of Bacterial Pathogenesis and Immunology, The Rockefeller University, New York, United States
    Competing interests
    No competing interests declared.
  9. David M Donovan

    Animal Biosciences and Biotechnology Lab, Agricultural Research Service, United States Department of Agriculture, Beltsville, United States
    Competing interests
    No competing interests declared.
  10. John Moult

    Institute for Bioscience and Biotechnology Research, University of Maryland, College Park, Rockville, United States
    Competing interests
    No competing interests declared.
  11. Vincent A Fischetti

    Laboratory of Bacterial Pathogenesis and Immunology, The Rockefeller University, New York, United States
    Competing interests
    Vincent A Fischetti, An inventor of U.S. patents(numbers 6,608,187, 7,582,729, and 7,838,255), which pertain to PlyC.
  12. Frank Heinrich

    Department of Physics, Carnegie Mellon University, Pittsburgh, United States
    Competing interests
    No competing interests declared.
  13. Mathias Lösche

    Department of Physics, Carnegie Mellon University, Pittsburgh, United States
    Competing interests
    No competing interests declared.
  14. Daniel C Nelson

    Institute for Bioscience and Biotechnology Research, University of Maryland, College Park, Rockville, United States
    For correspondence
    nelsond@umd.edu
    Competing interests
    Daniel C Nelson, An inventor of U.S. patents(numbers 6,608,187, 7,582,729, and 7,838,255), which pertain to PlyC.

Ethics

Human subjects: For primary epithelial cell cultures, the experimental protocol received Institutional Review Board approvals from both the Rockefeller University (VAF-0621-1207) and the Weill Cornell Medical College (nos. 0803009695 and 0806009857). Individual patient consent for the use of tissue in research applications was obtained prior to the surgical procedure.

Reviewing Editor

  1. Michael S Gilmore, Harvard Medical School, United States

Publication history

  1. Received: November 18, 2015
  2. Accepted: March 14, 2016
  3. Accepted Manuscript published: March 15, 2016 (version 1)
  4. Version of Record published: April 27, 2016 (version 2)

Copyright

This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.

Metrics

  • 3,712
    Page views
  • 839
    Downloads
  • 44
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, Scopus, PubMed Central.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Download citations (links to download the citations from this article in formats compatible with various reference manager tools)

Open citations (links to open the citations from this article in various online reference manager services)

  1. Further reading

Further reading

    1. Biochemistry and Chemical Biology
    Xavier Portillo et al.
    Research Article Updated

    An RNA polymerase ribozyme that has been the subject of extensive directed evolution efforts has attained the ability to synthesize complex functional RNAs, including a full-length copy of its own evolutionary ancestor. During the course of evolution, the catalytic core of the ribozyme has undergone a major structural rearrangement, resulting in a novel tertiary structural element that lies in close proximity to the active site. Through a combination of site-directed mutagenesis, structural probing, and deep sequencing analysis, the trajectory of evolution was seen to involve the progressive stabilization of the new structure, which provides the basis for improved catalytic activity of the ribozyme. Multiple paths to the new structure were explored by the evolving population, converging upon a common solution. Tertiary structural remodeling of RNA is known to occur in nature, as evidenced by the phylogenetic analysis of extant organisms, but this type of structural innovation had not previously been observed in an experimental setting. Despite prior speculation that the catalytic core of the ribozyme had become trapped in a narrow local fitness optimum, the evolving population has broken through to a new fitness locale, raising the possibility that further improvement of polymerase activity may be achievable.

    1. Biochemistry and Chemical Biology
    Gajanan S Patil et al.
    Research Article Updated

    Fatty acyl-AMP ligases (FAALs) channelize fatty acids towards biosynthesis of virulent lipids in mycobacteria and other pharmaceutically or ecologically important polyketides and lipopeptides in other microbes. They do so by bypassing the ubiquitous coenzyme A-dependent activation and rely on the acyl carrier protein-tethered 4′-phosphopantetheine (holo-ACP). The molecular basis of how FAALs strictly reject chemically identical and abundant acceptors like coenzyme A (CoA) and accept holo-ACP unlike other members of the ANL superfamily remains elusive. We show that FAALs have plugged the promiscuous canonical CoA-binding pockets and utilize highly selective alternative binding sites. These alternative pockets can distinguish adenosine 3′,5′-bisphosphate-containing CoA from holo-ACP and thus FAALs can distinguish between CoA and holo-ACP. These exclusive features helped identify the omnipresence of FAAL-like proteins and their emergence in plants, fungi, and animals with unconventional domain organizations. The universal distribution of FAALs suggests that they are parallelly evolved with FACLs for ensuring a CoA-independent activation and redirection of fatty acids towards lipidic metabolites.